251 related articles for article (PubMed ID: 22651893)
1. Guideline for the diagnosis and management of myelofibrosis.
Reilly JT; McMullin MF; Beer PA; Butt N; Conneally E; Duncombe A; Green AR; Michaeel NG; Gilleece MH; Hall GW; Knapper S; Mead A; Mesa RA; Sekhar M; Wilkins B; Harrison CN;
Br J Haematol; 2012 Aug; 158(4):453-71. PubMed ID: 22651893
[TBL] [Abstract][Full Text] [Related]
2. Guideline on the prevention of secondary central nervous system lymphoma: British Committee for Standards in Haematology.
McMillan A; Ardeshna KM; Cwynarski K; Lyttelton M; McKay P; Montoto S;
Br J Haematol; 2013 Oct; 163(2):168-81. PubMed ID: 24033102
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for the laboratory investigation of heritable disorders of platelet function.
Harrison P; Mackie I; Mumford A; Briggs C; Liesner R; Winter M; Machin S;
Br J Haematol; 2011 Oct; 155(1):30-44. PubMed ID: 21790527
[TBL] [Abstract][Full Text] [Related]
4. Guideline on aspects of cancer-related venous thrombosis.
Watson HG; Keeling DM; Laffan M; Tait RC; Makris M;
Br J Haematol; 2015 Sep; 170(5):640-8. PubMed ID: 26114207
[TBL] [Abstract][Full Text] [Related]
5. [Idiopathic myelofibrosis in internal medicine].
García-Gutiérrez V; Redondo S; Ruedas A
Med Clin (Barc); 2014 Dec; 143(11):498-501. PubMed ID: 25088655
[No Abstract] [Full Text] [Related]
6. Evidence creation for myelofibrosis: Challenges and opportunities.
Gupta V
Br J Haematol; 2024 Jan; 204(1):19-21. PubMed ID: 38083995
[TBL] [Abstract][Full Text] [Related]
7. Alleviating anemia and thrombocytopenia in myelofibrosis patients.
Cervantes F; Correa JG; Hernandez-Boluda JC
Expert Rev Hematol; 2016 May; 9(5):489-96. PubMed ID: 26891375
[TBL] [Abstract][Full Text] [Related]
8. The management of myelofibrosis: A British Society for Haematology Guideline.
McLornan DP; Psaila B; Ewing J; Innes A; Arami S; Brady J; Butt NM; Cargo C; Cross NCP; Francis S; Frewin R; Garg M; Godfrey AL; Green A; Khan A; Knapper S; Lambert J; McGregor A; McMullin MF; Nangalia J; Neelakantan P; Woodley C; Mead A; Somervaille TCP; Harrison CN;
Br J Haematol; 2024 Jan; 204(1):136-150. PubMed ID: 38037886
[No Abstract] [Full Text] [Related]
9. Primary myelofibrosis and its targeted therapy.
Shantzer L; Berger K; Pu JJ
Ann Hematol; 2017 Apr; 96(4):531-535. PubMed ID: 27539616
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis.
Murata M; Suzuki R; Nishida T; Shirane S; Shimazu Y; Minami Y; Mori T; Doki N; Kanda Y; Uchida N; Tanaka M; Ishikawa J; Togitani K; Fukuda T; Ichinohe T; Atsuta Y; Nagamura-Inoue T; Kiyoi H
Intern Med; 2020; 59(16):1947-1956. PubMed ID: 32801269
[TBL] [Abstract][Full Text] [Related]
11. Myelofibrosis: challenges for preclinical models and emerging therapeutic targets.
Morsia E; Gangat N
Expert Opin Ther Targets; 2021 Mar; 25(3):211-222. PubMed ID: 33844952
[No Abstract] [Full Text] [Related]
12. Myelofibrosis with myeloid metaplasia.
Tefferi A
N Engl J Med; 2000 Apr; 342(17):1255-65. PubMed ID: 10781623
[No Abstract] [Full Text] [Related]
13. Managing patients with myelofibrosis and low platelet counts.
Al-Ali HK; Vannucchi AM
Ann Hematol; 2017 Apr; 96(4):537-548. PubMed ID: 27209535
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.
McLornan DP; Godfrey AL; Green A; Frewin R; Arami S; Brady J; Butt NM; Cargo C; Ewing J; Francis S; Garg M; Harrison C; Innes A; Khan A; Knapper S; Lambert J; Mead A; McGregor A; Neelakantan P; Psaila B; Somervaille TCP; Woodley C; Nangalia J; Cross NCP; McMullin MF;
Br J Haematol; 2024 Jan; 204(1):127-135. PubMed ID: 37932932
[No Abstract] [Full Text] [Related]
15. Allogeneic stem cell transplantation for myelofibrosis in 2012.
McLornan DP; Mead AJ; Jackson G; Harrison CN
Br J Haematol; 2012 May; 157(4):413-25. PubMed ID: 22463701
[TBL] [Abstract][Full Text] [Related]
16. Practical management of myelofibrosis with ruxolitinib.
Ho PJ; Marlton P; Tam C; Stevenson W; Ritchie D; Bird R; Dunlop LC; Durrant S; Ross DM
Intern Med J; 2015 Dec; 45(12):1221-30. PubMed ID: 26648193
[TBL] [Abstract][Full Text] [Related]
17. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 6. Management of myelofibrosis].
Takenaka K; Akashi K
Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):1969-76. PubMed ID: 22897001
[No Abstract] [Full Text] [Related]
18. Diagnosis and management of Waldenström macroglobulinaemia-A British Society for Haematology guideline.
Pratt G; El-Sharkawi D; Kothari J; D'Sa S; Auer R; McCarthy H; Krishna R; Miles O; Kyriakou C; Owen R
Br J Haematol; 2022 Apr; 197(2):171-187. PubMed ID: 35020191
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic myelofibrosis: historical review, diagnosis and management.
Weinstein IM
Blood Rev; 1991 Jun; 5(2):98-104. PubMed ID: 1912760
[TBL] [Abstract][Full Text] [Related]
20. A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK.
Harrison CN; Mead AJ; Drummond MW; Chiu G; Bains R
Br J Haematol; 2020 Mar; 188(6):e105-e109. PubMed ID: 32077091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
